Appendix 8.5.2.1

Criteria for Identifying Patients with Potentially Clinically Significant Changes in Clinical

Chemistry Variables

 

Chemistry Test

Gender

Ages

Low

High

Total Bilirubin

M/F

All

<0.12 mg/dL

>2.0 mg/dL

Alkaline Phosphatase

M

15-19

--

>500 U/L

F

--

>200 U/L

M/F

20-58

--

>200 U/L

M/F

≥59 yrs

--

>230 U/L

ALT (SGPT)

M

≤68 yrs

--

>86 U/L

F

--

>68 U/L

M

≥69 yrs

--

>70 U/L

F

--

>64 U/L

AST (SGOT)

M

All

--

>72 U/L

F

--

>68 U/L

Creatinine

M

All

<0.6 mg/dL

>1.9 mg/dL

F

<0.6 mg/dL

>1.7 mg/dL

Glucose

M/F

<59 yrs

<56 mg/dL

>172 mg/dL

M/F

≥59 yrs

<56 mg/DL

>180 mg/dL

Albumin

M/F

<69 yrs

<2.6 g/dL

>5.9 g/dL

M/F

≥69 yrs

<2.8 g/dL

>5.5 g/dL

Sodium

M/F

<59 yrs

<125 mEq/L

>154 mEq/L

 

M/F

≥59 yrs

<128 mEq/L

>152 mEq/L

Potassium

M/F

All

<3.1 mEq/L

>5.7 mEq/L

Bicarbonate

M/F

All

<18.6 mEq/L

>37.7 mEq/L

                               

 

Bupropion Sustained-Release Clinical Review                   61

 

 

Back a Page
Next Page
Back to Wellbutrin SRŪ NDA Index Page
Back to Main Index

Hosted by www.Geocities.ws

1